Clinical Trials Sponsored by Instituto de Gastroenterología

Total 5706 results

Institut de Cancérologie de Lorraine

Completed

Agreement Between Oral and Cervical Human Papillomavirus Infection in a French Cohort (PAPILLOR)

Human Papillomavirus-Related Cervical Carcinoma

France
Institut de Cancérologie de Lorraine

Completed

HE4 as a Relapse Biomarker in Ovarian Cancers (PRONOV4IR)

Ovarian Carcinoma

France
Institut de Cancérologie de Lorraine

Completed

Determination of the Feasibility of Tumoural Somatic Mutations Detection in Blood of Patients With Ovarian Cancer (BOVARY Pilot)

Ovarian Cancer

France
Institut de Cancérologie de Lorraine

Completed

CaptHPV : Validation of the Method "CaptHPV" for the Diagnosis of Human Papillomavirus Associated Infiltrating Carcinomas (CaptHPV)

Cervical Cancer | Vulvar Cancer | Anal Cancer | Oropharynx Cancer | Oral Cavity Cancer | Penis Cancer

France
Institut de Cancérologie de Lorraine

Completed

Detection of KRAS, NRAS et BRAF Mutations in Plasma Circulating DNA From Patients With Metastatic Colorectal Cancer (ColoBEAM)

Colorectal Cancer Metastatic

France
Institut de Cancérologie de Lorraine

Completed

Interest of Self-compression Technique on Tolerance of Mammography (ITACTs)

Breast Cancer

France
Institut de Cancérologie de Lorraine

Completed

Technical Optimization of Detection of KRAS, BRAF and NRAS Mutations on Tumor DNA Circulating in Metastatic Colorectal Cancer (CircuLOR-1)

Metastatic Colorectal Cancer

France
Institut de Cancérologie de Lorraine

Completed

Understanding Low Gynecological Cancer Delay and Help-seeking Behavior in Older Patients. (CODEGY65)

Gynecologic Cancer | Aged | Symptoms and Signs

France
Institut de Cancérologie de Lorraine

Completed

Detection in Peripheral Blood of Circulating Tumor Cells in Patient With Head and Neck Squamous Cell Carcinoma (CTCVADS)

Head and Neck Cancer

France
Institut de Cancérologie de Lorraine

Completed

Prognostic Impact of Programmed Death Ligand-1 Expression in Advanced Endometrial Cancer

Endometrial Cancer
Institut de Cancérologie de Lorraine

Completed

Sarcopenia is an Independent Prognostic Factor for Overall Survival in Patients With Pancreatic Adenocarcinoma

Pancreatic Neoplasms
Institut de Cancérologie de Lorraine

Completed

Intensity-modulated Radiation Therapy From 70Gy to 80Gy in Localized Prostate Cancer

Prostate Cancer
Universidad de Santander
Instituto de Salud de Bucaramanga

Unknown

Trial of Supplementation With Aged Garlic Extract to Improve Endothelial Function in Patients With Metabolic Syndrome (Kymes)

Metabolic Syndrome

Colombia
Instituto Nacional de Cancerologia de Mexico

Recruiting

Ceftolozane/Tazobactam vs. Piperacillin/Tazobactam for the Treatment of Bacteremia in Hemato-oncological Patients

Hematologic Neoplasms | Neutropenia

Mexico
Instituto de Investigación Marqués de Valdecilla

Not yet recruiting

Mepolizumab and In-office Nasal Polypectomy in Patients With Chronic Rhinosinusitis (CRS). A Three Arm Study. (MELYSA)

Rhinosinusitis Chronic | Polyp, Nasal

Spain
Instituto Nacional de Cancerologia de Mexico

Recruiting

Glutamine Plus L. Reuteri Prevents TKI Therapy-diarrhea in Patients With NSCLC

Non-Small Cell Lung Cancer With EGFR Mutation

Mexico
Instituto de Investigación Marqués de Valdecilla

Not yet recruiting

Evaluate the Efficacy, Safety and Tolerability of Fecal Microbiota Transfer for the Treatment of Patients With Nonalcoholic Steatohepatitis (EMOTION)

Patients With Nonalcoholic Steatohepatitis
Instituto de Investigación Marqués de Valdecilla

Recruiting

Prophylaxis of Cytomegalovirus Infection With Adoptive Cell Inmunotherapy (INMUNOCELL)

CMV

Spain
Instituto Nacional de Cancerologia de Mexico

Completed

Ketamine or Placebo in Patients With Major Depression and Advanced Cancer (KODIAC)

Major Depressive Disorder | Advanced Cancer

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Tetracycline as a Prophylaxis for Rash in Patients With NSCLC Receiving Treatment With BIBW2992 (Afatinib)

Lung Cancer | Skin Rash

Mexico
Instituto de Cardiologia de Santa Catarina

Unknown

Prevention of Radial Artery Occlusion After Transradial Access Using Nitroglycerin (Patens)

Injury of Radial Artery

Brazil
Instituto Nacional de Cancerologia de Mexico

Unknown

Effectiveness and Quality of Life Analysis of Palonosetron Against Ondansetron Combined With Dexamethasone and Fosaprepitant in Prevention of Acute and Delayed Emesis Associated to Chemotherapy Moderate and Highly Emetogenic in Breast Cancer.

Quality of Life | Breast Neoplasm | Antineoplastic Agents | Antiemetics

Mexico
Instituto de Investigación Marqués de Valdecilla

Completed

Program of Screening, Prevention and Elimination of Hepatitis C in Penitentiary Institutions in Cantabria (JAILFREE-C) (JAILFREE-C)

Hepatitis C

Spain
Instituto Nacional de Cancerologia de Mexico

Unknown

ALK Rearrangements in Lung Adenocarcinoma: Epidemiology in Latin America (CLICaP)

Lung Cancer

Mexico
Instituto de Cardiologia de Santa Catarina

Unknown

Post-Myocardial Infarction Patients in Santa Catarina, Brazil - Catarina Heart Study (Catarina)

Myocardial Infarction

Brazil
Instituto Nacional de Cancerologia de Mexico

Completed

Early Incorporation of Patient and Family to Attention and Care Program in Oncology Versus Standard of Care (PACO)

Lung Neoplasms

Mexico
Instituto Nacional de Cancerologia de Mexico

Unknown

Nabilone Effect on the Attenuation of Anorexia, Nutritional Status and Quality of Life in Lung Cancer Patients

Anorexia | Non-Small Cell Lung Cancer | Cachexia | Weight Lose

Mexico
Instituto de Investigación Marqués de Valdecilla

Unknown

Safety and Efficacy of Bemiparin in the Prevention of Thrombotic Events in Hospitalized Cirrhotic Patients (BEMI-2015)

Cirrhosis and Coagulation
Instituto de Cardiologia de Santa Catarina

Completed

Cardiovascular Effects of a Soccer Match in Viewers With With Coronary Artery Disease

Coronary Artery Disease

Brazil
Instituto de Investigación Marqués de Valdecilla

Recruiting

A Population-based Cohort in Northern Spain (COHORTE)

Chronic Disease

Spain
Instituto de Investigación Marqués de Valdecilla

Recruiting

Cost-effectiveness of a Transdiagnostic Psychological Treatment for Emotional Disorders in Primary Care (PsicAP-Costs2)

Emotional Disorder

Spain
Instituto Nacional de Cardiologia de Laranjeiras

Recruiting

Cerebral Oxygen Saturation Monitoring In Cardiac Surgery (COSMICS) (COSMICS)

Cognitive Dysfunction | Cardiac Disease

Brazil
Instituto de Investigación Marqués de Valdecilla

Recruiting

Efficacy and Safety of Endoscopic Sleeve Gastroplasty Versus Laparoscopic Sleeve Gastrectomy in Obese Subjects With NASH (TESLA-NASH)

Non-alcoholic Steatohepatitis (NASH)

Spain
Instituto Nacional de Cancerologia de Mexico

Completed

Treatment With BIBW 2992, Irreversible Inhibitor of EGFR and HER-2 in Non-small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer | EGFR | HER-2

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Radical Treatment of Synchronous Oligometastatic Non-Small Cell Lung Carcinoma

Carcinoma, Non-Small-Cell Lung | Synchronous Neoplasms

Mexico
Instituto de Investigación Marqués de Valdecilla

Terminated

TO ASSESS THE EFFECTIVENESS OF THE INTERVENTION OF THE LOW-SODIUM DIET IN PATIENTS WITH HTA (IDI-HTA2020)

Arterial Hypertension | Diet Habit | Sodium Urine | Primary Care Center

Spain
Instituto Valenciano de Infertilidade de Lisboa

Completed

Spermatozoa Morphology Selection by Thermotaxis

Male Infertility

Portugal
Instituto de Investigación Marqués de Valdecilla

Withdrawn

Randomized, Controlled, Double-blind Clinical Trial Comparing the Efficacy and Safety of Chemoprophylaxis With Hydroxychloroquine in Patients Under Biological Treatment and / or JAK Inhibitors in the Prevention of SARS-CoV-2 Infection

COVID 19 | Immunomediated Inflammatory Disease in Treatment With Biological Agents and / or Jak Inhibitors
Instituto Nacional de Cancerologia de Mexico

Completed

Results From a Mexican Acute Promyelocytic Leukemia. (Mexico APL)

Promyelocytic Leukemia, Acute

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Nitroglycerin Plus Intracranial Radiotherapy for Brain Metastases in NSCLC Patients

Phase II Clinical Trial | Ninety-six Histologically Confirmed NSCLC Patients With BM | Randomized 1:1 to Received TN Plus WBR or Only WBR | ICPFS Evaluated by Two Blinded and Independent Radio-oncologist With MRI

Mexico
Instituto de Investigación Marqués de Valdecilla

Unknown

Minimally Invasive Right Colectomy Anastomosis Study (MIRCAST)

Colorectal Cancer | Colectomy | Anastomotic Complication

Spain, Finland, Germany, Italy, Croatia, Denmark, France, Greece, Portugal, United Kingdom
Instituto de Investigación Marqués de Valdecilla

Unknown

A Novel Hepatitis c micrOelimination Program in Non imprisonEd SenTenced With Alternative Measures (HONEST)

Mental Disease | Hepatotropic Virus Infection | Addictive Behaviours o Conducts | People Sentenced to Non-custodial Sentences

Spain
Instituto Nacional de Cancerologia de Mexico

Completed

Clinicopathological Features of NSCLC Patients Associated With the Chromosome 2p (EML4-ALK) (ALK)

Non Small-cell Lung Cancer

Mexico
Instituto Nacional de Cancerologia de Mexico

Unknown

Metformin Plus TKI Use in Patients With Non-Small Cell Lung Carcinoma

EGFR Gene Mutation | Tyrosine Kinase Mutation | Non-Small Cell Adenocarcinoma

Mexico
Instituto Nacional de Cancerologia de Mexico

Unknown

Evaluation of PD1 / PDL1 Expression on Blood Cells & Tumor Tissue, Their Role as a Prognostic Target in NSCLC Patients

Non-Small Cell Lung Cancer

Mexico
Instituto Nacional de Cancerologia de Mexico

Recruiting

Nitroglycerin Plus Radiotherapy Versus Conventional Radiotherapy in Patients With Lung Cancer.

Non-small Cell Lung Cancer | Brain Metastases | EGFR Gene Mutation

Mexico
Instituto Nacional de Cancerologia de Mexico

Recruiting

Alectinib Pharmacokinetic in Patients With NSCLC

ALK Gene Mutation | Non-small Cell Lung Cancer Stage IIIB

Mexico
Instituto de Investigación Marqués de Valdecilla

Recruiting

Big Data Analysis of OSA Patients on Positive Airway Pressure (PAP) Treatment: Real-life Monitoring (TeleVAL)

Obstructive Sleep Apnea | Positive Airway Pressure

Spain
Instituto Nacional de Cancerologia de Mexico

Recruiting

Metformin Plus Tyrosine Kinase Inhibitors for Treatment of Patients With Non-small Cell Lung Cancer With EGFR Mutations (METLUNG)

Non Small Cell Lung Cancer

Mexico
Instituto Nacional de Cancerologia de Mexico

Recruiting

HIPEC in Ovarian Carcinoma Clinical Stage IIIC and IV During Interval Laparotomy

Ovarian Cancer | Chemotherapy Effect | HPEC | Women's Health: Neoplasm of Ovary

Mexico

Clinical Trials Sponsored by Instituto de Gastroenterología

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Djibouti

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations